Palisade Bio, Inc. (PALI)
PALI Stock Price Chart
Explore Palisade Bio, Inc. interactive price chart. Choose custom timeframes to analyze PALI price movements and trends.
PALI Company Profile
Discover essential business fundamentals and corporate details for Palisade Bio, Inc. (PALI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Mar 2007
Employees
8.00
Website
https://www.palisadebio.comCEO
J. D. Finley
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.
PALI Financial Timeline
Browse a chronological timeline of Palisade Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.32.
Earnings released on 11 Aug 2025
EPS came in at -$0.58 falling short of the estimated -$0.48 by -20.83%.
Earnings released on 12 May 2025
EPS came in at -$0.47 surpassing the estimated -$0.84 by +44.05%.
Earnings released on 24 Mar 2025
EPS came in at -$0.69 surpassing the estimated -$1.99 by +65.33%, while revenue for the quarter reached $4.00K .
Earnings released on 12 Nov 2024
EPS came in at -$2.32 surpassing the estimated -$3.35 by +30.75%.
Earnings released on 12 Aug 2024
EPS came in at -$3.32 falling short of the estimated -$2.93 by -13.31%.
Earnings released on 13 May 2024
EPS came in at -$4.59 surpassing the estimated -$4.80 by +4.38%.
Stock split effective on 8 Apr 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Mar 2024
EPS came in at -$3.75 surpassing the estimated -$5.17 by +27.47%, while revenue for the quarter reached -$250.00K .
Earnings released on 9 Nov 2023
EPS came in at -$7.35 falling short of the estimated -$0.39 by -1.78K%.
Earnings released on 11 Aug 2023
EPS came in at -$7.95 falling short of the estimated -$0.45 by -1.67K%.
Earnings released on 12 May 2023
EPS came in at -$8.10 falling short of the estimated -$0.72 by -1.03K%, while revenue for the quarter reached $250.00K .
Earnings released on 22 Mar 2023
EPS came in at $6.47 surpassing the estimated -$2.43 by +366.26%.
Stock split effective on 16 Nov 2022
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$59.97 falling short of the estimated -$4.00 by -1.40K%.
Earnings released on 15 Aug 2022
EPS came in at -$89.96 falling short of the estimated -$8.50 by -958.35%.
Earnings released on 13 May 2022
EPS came in at -$194.90 surpassing the estimated -$210.00 by +7.19%.
Earnings released on 16 Mar 2022
EPS came in at $554.72 surpassing the estimated -$11.75 by +4.82K%.
Earnings released on 15 Nov 2021
EPS came in at -$224.89 falling short of the estimated -$18.00 by -1.15K%.
Earnings released on 24 Aug 2021
EPS came in at -$3.07K .
Earnings released on 14 May 2021
EPS came in at -$16.98 .
Stock split effective on 28 Apr 2021
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 22 Mar 2021
EPS came in at -$17.88 , while revenue for the quarter reached $2.50K .
Earnings released on 10 Nov 2020
EPS came in at -$7.76 , while revenue for the quarter reached $2.50K .
PALI Stock Performance
Access detailed PALI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.